Search Press releases Keywords From To 20 Jun 2023 UCB showcases commitment to transforming outcomes for people living with epilepsy and rare epileptic syndromes at European Pediatric Neurology Society (EPNS) Annual Congress Read More 7 Jun 2023 UCB Receives New European Commission Approvals for BIMZELX[®]▼(bimekizumab) for the Treatment of Psoriatic Arthritis and Axial Spondyloarthritis Read More 31 May 2023 New Long-Term Data on Bimekizumab in Psoriatic Arthritis and Axial Spondyloarthritis Presented at EULAR 2023 Read More 30 May 2023 UCB Showcases Commitment to Advancing Care in Immune-Mediated Inflammatory Diseases with 23 Abstracts at EULAR 2023 Read More 26 May 2023 Transparency notification FMR LLC Read More 23 May 2023 UCB and Veeva collaborate to advance the patient experience in clinical trials Read More Pagination First page Previous page Previous … Page 30 Page 31 Page 32 Page 33 Current page 34 Page 35 Page 36 Page 37 Page 38 … Page 34 of 65 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
